Galderma (U.K) Ltd

Meridien House, 69-71 Clarendon Road, Watford, Hertfordshire, WD17 1DS, UK
Telephone: +44 (0)1923 208950
Fax: +44 (0)1923 208998
Summary of Product Characteristics last updated on the eMC: 24/08/2009
SPC Silkis 3 micrograms per g ointment

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 24/08/2009 and displayed until Current
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
Date of revision of text on the SPC:   03-Aug-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 6.5 - Addition of standard text ' Not all pack sizes may be marketed'.

Updated on 01/11/2007 and displayed until 24/08/2009
Reasons for adding or updating:
  • Change to section 4.8 - Undesirable Effects
Date of revision of text on the SPC:   01/2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Update to section 4.8 - Undesirable effects

Updated on 07/03/2007 and displayed until 01/11/2007
Reasons for adding or updating:
  • Removal of Black Triangle
Date of revision of text on the SPC:   03/2004
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Black triangle has been removed
Updated on 03/08/2004 and displayed until 07/03/2007
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 03/08/2004 and displayed until 03/08/2004
Reasons for adding or updating:
  • Change to section 1 - trade name
  • Change to section 3 - pharmaceutical form
  • Change to section 4.3 - Contra-indications
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.8 - Undesirable Effects
  • Change to section 6.1 - List of Excipients
  • Change to section 6.2 - Incompatibilities
  • Change to section 6. 3 - Shelf Life
  • Change to section 6. 6 - Instruction for Use/Handling
  • Change to section 10 (date of (partial) revision of the text
Updated on 17/09/2003 and displayed until 03/08/2004
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
  • Addition of Legal Category
Updated on 06/08/2002 and displayed until 17/09/2003
Reasons for adding or updating:
  • Change to section 2 - qualitative and quantitative composition
  • Change to section 3 - pharmaceutical form
  • Change to section 4.1 - Therapeutic Indications
  • Change to section 4.2 - Posology and Method of Administration
  • Change to section 4.4 - Special Warnings and Precautions for Use
  • Change to section 4.6 - Pregnancy and Lactation
  • Change to section 5.2 - Pharmacokinetic Properties
  • Change to section 5.3 - Preclinical Safety Data
  • Change to section 6.2 - Incompatibilities
  • Change to section 6. 3 - Shelf Life
  • Change to section 6. 4 - Special Precautions for Storage
  • Change to section 10 (date of (partial) revision of the text
Updated on 29/04/2002 and displayed until 06/08/2002
Reasons for adding or updating:
  • New SPC for new product

Active Ingredients/Generics

 
   calcitriol


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk